CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Director bought 2,982 shares at an average $2.98 ($8,881)
- 4 Open-market buy Director bought 882 shares at an average $2.98 ($2,627)
- 4 Open-market buy Director bought 1,785 shares at an average $2.98 ($5,316)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.98 ($6,567)
- 4 Open-market buy Director bought 1,785 shares at an average $3.26 ($5,827)
- 4 Open-market buy Director bought 2,414 shares at an average $3.32 ($8,005)
- 4 Open-market buy Director bought 714 shares at an average $3.32 ($2,368)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,310 shares at an average $3.25 ($7,505)
- 4 Grant or award Director acquired 2,040 shares (grant or award)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 3,150 shares at an average $3.01 ($9,495)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 3,465 shares (grant or award)
- 4 Shares withheld for taxes Chairman and CEO gave up 37,350 shares (to pay taxes)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 2,560 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 2,870 shares (to pay taxes)
Page 12 of 26 · 512 filings